steroids 7 1 ( 2 0 0 6 ) 96–101
99
5.48 (s, 1H, 6-H), 7.29–7.37 (m, 5H, Ph). 13C NMR (CDCl3) ı: −4.8,
−4.6, −4.5, 11.3, 17.9, 18.1, 18.2, 20.9, 25.8, 25.9, 27.0, 30.7, 32.0,
36.5, 36.7, 37.1, 37.8, 42.4, 43.7, 44.4, 45.9, 71.5, 71.8, 73.3, 76.4,
81.3, 126.2, 127.6, 127.6, 128.3, 138.3, 144.5. EIMS m/z: 654 [M]+
(2), 636 [M − H2O]+ (22), 533 (100), 515 (20), 401(16), 91 (39), 73
(CDCl3) ı: −4.8, −4.7, −4.4, 11.0, 18.1, 18.4, 19.3, 20.9, 25.9, 25.9,
26.6, 31.0, 32.1, 36.7, 37.3, 37.7, 42.5, 43.1, 43.5, 43.6, 43.9, 46.5,
72.9, 74.1, 81.4, 126.2, 127.8, 129.0, 131.0, 137.5, 141.0. EIMS m/z:
624 [M]+ (<1), 606 [M − H2O]+ (44), 533 (100), 515 (8), 474 (14),
401 (15), 73 (13). HREIMS calculated for C38H64O3Si2 624.4394,
found 624.4385.
(27). HREIMS calculated for C39H
66O4Si2 [M]+ 654.4500, found
654.4463; and 9b (60 mg, 48.8% yield), which was recrystallized
from n-hexane to give an analytical sample: white solid, mp
114–116 ◦C. [˛]D20 − 32.1 (c 1.90, n-C6H14). IR (KBr) ꢀmax (cm−1):
3440 (OH), 2956, 2856, 1667 (C C). 1H NMR (CDCl3) ı: 0.01 (s, 6H,
(CH3)2Si), 0.08 (s, 6H, (CH3)2Si), 0.69 (s, 3H, 18-CH3), 0.88 (s, 9H,
(CH3)3CSi), 0.90 (s, 9H, (CH3)3CSi), 1.05 (s, 3H, 19-CH3), 3.42 (d,
1H, J = 9.0 Hz, 7-CH2OBn), 3.46–3.55 (m, 2H, 3-H, 17-H), 3.56 (d,
1H, J = 9.0 Hz, 7-CH2OBn), 4.52 (d, 1H, J = 12.6 Hz, CH2Ph), 4.60 (d,
1H, J = 12.6 Hz, CH2Ph), 5.31 (s, 1H, 6-H), 7.30–7.38 (m, 5H, Ph).
13C NMR (CDCl3) ı: −4.5, −4.2, −4.1, 11.1, 18.4, 18.5, 19.3, 21.0,
26.2, 26.2, 27.0, 31.1, 32.3, 36.7, 37.6, 37.6, 42.2, 42.7, 43.9, 44.5,
46.4, 72.7, 73.7, 74.3, 74.6, 81.6, 127.6, 127.8, 127.9, 128.6, 138.6,
143.2. EIMS m/z: 654 [M]+ (1), 636 [M − H2O]+ (20), 533 (100),
401(16), 91 (33), 73 (23). Analysis calculated for C39H66O4Si2:
C, 71.50; H, 10.15; found: C, 71.35; H, 10.38.
2.9.
3ˇ,17ˇ-Di(tert-butyldimethylsilyloxy)-7ˇ-
allylandrost-5-en-7˛-ol 8a and
3ˇ,17ˇ-di(tert-butyldimethylsilyloxy)-7˛-allylandrost-5-
en-7ˇ-ol 8b
Under similar conditions to those for the preparation of 7a
and 7b, 1 (100 mg, 0.19 mmol) was reacted with allyl bro-
mide (0.04 mL, 0.46 mmol) to afford a residue, which was chro-
matographed on silica. Elution with petroleum ether/ethyl
acetate (30:1) gave 8a (55 mg, 51.0% yield): colorless oil, [˛]D20
−
20.3 (c 0.93, n-C6H14). IR (KBr) ꢀmax (cm−1): 3446 (OH), 3065
(C C), 2929, 2854, 1639 (C C). 1H NMR (CDCl3) ␦: 0.01 (d,
6H, J = 1.2 Hz, (CH3)2Si), 0.05 (s, 6H, (CH3)2Si), 0.71 (s, 3H, 18-
CH3), 0.87 (s, 9H, (CH3)3CSi), 0.88 (s, 9H, (CH3)3CSi), 0.91 (s,
3H, 19-CH3), 3.44–3.53 (m, 1H, 3-H), 3.56 (t, 1H, J = 8.0 Hz,
17-H), 5.01 (d, 1H, J = 17.2 Hz, 7-CH2CH CH2), 5.06 (d, 1H,
J = 10.0 Hz, 7-CH2CH CH2), 5.18 (s, 1H, 6-H), 5.56–5.67 (m, 1H,
7-CH2CH CH2). 13C NMR (CDCl3) ı: −4.8, −4.6, −4.5, 11.3, 17.9,
18.1, 18.2, 20.9, 25.8, 25.9, 27.1, 31.0, 32.0, 36.5, 36.8, 37.1, 38.5,
42.2, 43.8, 44.9, 46.2, 46.2, 71.8, 72.0, 81.4, 118.0, 128.1, 134.6,
145.3. EIMS m/z: 574 [M]+ (1), 556 [M − H2O]+ (13), 533 (100),
515 (31), 424 (16), 401 (11), 57 (17). HREIMS calculated for
2.11. 3ˇ,17ˇ-Di(tert-butyldimethylsilyloxy)-7ˇ-(2-
ethoxy-2-oxoethyl)androst-5-en-7˛-ol 10a and
3ˇ,17ˇ-di(tert-butyldimethylsilyloxy)-7˛-(2-ethoxy-2-
oxoethyl)androst-5-en-7ˇ-ol 10b
HMPA (0.4 mL, 2.29 mmol) was added to a solution of SmI2
in THF (0.1 M, 8 mL). The deep purple solution was stirred
for 15 min at room temperature, then cooled to −78 ◦C, and
stirred at this temperature for 30 min. A mixture of 1 (100 mg,
0.19 mmol) and ethyl bromoacetate (0.04 mL, 0.36 mmol) in
THF (3 mL) was added dropwise, and the reaction mixture
was stirred at −78 ◦C for 20 min. The mixture was then
warmed to 0 ◦C gradually and stirred at this temperature
for 2 h. The reaction was quenched with 0.1N HCl, and
then, extracted with ethyl acetate (30 mL × 3). The combined
extracts were washed sequentially with saturated Na2S2O3,
saturated NaHCO3, and brine, dried over anhydrous Na2SO4,
and concentrated in vacuo. The crude mixture was chro-
matographed with petroleum ether/ethyl acetate (15:1) to give
10a (21 mg, 18.0% yield): colorless oil, [˛]2D0 − 19.5 (c 0.83, n-
C6H14). IR (KBr) ꢀmax (cm−1): 3462 (OH), 2928, 1732, 1714 (C O).
1H NMR (CDCl3) ı: 0.01 (d, 6H, J = 3.2 Hz, (CH3)2Si), 0.05 (s,
6H, (CH3)2Si), 0.72 (s, 3H, 18-CH3), 0.88 (s, 18H, 2 × (CH3)3CSi),
0.94 (s, 3H, 19-CH3), 1.26 (t, 3H, J = 7.2 Hz, OCH2CH3), 2.36 (d,
1H, J = 15.2 Hz, 7-CH2CO), 2.79 (d, 1H, J = 15.2 Hz, 7-CH2CO),
3.50–3.60 (m, 2H, 3-H, 17-H), 4.15 (q, 2H, J = 7.2 Hz, OCH2CH3),
5.35 (s, 1H, 6-H). 13C NMR (CDCl3) ı: −4.8, −4.6, −4.5, 11.2,
14.2, 17.9, 18.1, 18.2, 20.8, 25.9, 25.9, 27.1, 30.9, 32.0, 36.6, 37.0,
37.0, 40.7, 42.3, 43.8, 44.3, 45.4, 45.8, 60.5, 70.3, 71.7, 81.3, 126.4,
144.5, 172.4. EIMS m/z: 602 [M − H2O]+ (6), 545 (100), 244 (6), 73
(10). HREIMS calculated for C35H62O4Si2 [M − H2O]+ 602.4187,
found 602.4180; and 10b (71 mg, 60.9% yield): colorless oil,
[˛]2D0 − 22.2 (c 2.15, n-C6H14). IR (KBr) ꢀmax (cm−1): 3512 (OH),
2929, 2854, 1732, 1709 (C O). 1H NMR (CDCl3) ı: 0.01 (d, 6H,
J = 2.4 Hz, (CH3)2Si), 0.04 (s, 6H, (CH3)2Si), 0.72 (s, 3H, 18-CH3),
0.87 (s, 18H, 2 × (CH3)3CSi), 1.05 (s, 3H, 19-CH3), 1.28 (t, 3H,
J = 7.2 Hz, OCH2CH3), 2.41 (d, 1H, J = 14.4 Hz, 7-CH2CO), 2.60 (d,
1H, J = 14.4 Hz, 7-CH2CO), 3.41–3.49 (m, 1H, 3-H), 3.52 (t, 1H,
C34H62O3Si2 574.4238, found 574.4209; and 8b (51 mg, 47.3%
yield): colorless oil, [˛]2D0 − 13.8 (c 1.1, n-C6H14). IR (KBr) ꢀmax
(cm−1): 3469 (OH), 3074 (C C), 2928, 2852, 1639 (C C). 1H
NMR (CDCl3) ı: 0.01 (d, 6H, J = 2.4 Hz, (CH3)2Si), 0.06 (s, 6H,
(CH3)2Si), 0.72 (s, 3H, 18-CH3), 0.88 (s, 9H, (CH3)3CSi), 0.89 (s,
9H, (CH3)3CSi), 1.04 (s, 3H, 19-CH3), 3.42–3.50 (m, 1H, 3-H)), 3.54
(t, 1H, J = 8.0 Hz, 17-H), 5.09 (d, 1H, J = 17.2 Hz, 7-CH2CH CH2),
5.13 (d, 1H, J = 9.2 Hz, 7-CH2CH CH2), 5.15 (s, 1H, 6-H), 5.88–5.97
(m, 1H, 7-CH2CH CH2). 13C NMR (CDCl3) ı: −4.9, −4.6, −4.5,
10.9, 18.1, 18.2, 19.1, 20.8, 25.8, 25.9, 26.5, 30.9, 32.0, 36.6, 37.2,
37.4, 41.9, 42.4, 43.4, 43.4, 43.8, 46.1, 72.6, 73.9, 81.3, 118.2,
128.5, 134.6, 141.7. EIMS m/z: 574 [M]+ (<1), 556 [M − H2O]+
(10), 533 (100), 424 (8), 401 (14), 73 (10). HREIMS calculated for
C
34H62O3Si2 574.4237, found 574.4241.
2.10. 3ˇ,17ˇ-Di(tert-butyldimethylsilyloxy)-7ˇ-
benzyloxymethylandrost-5-en-7˛-ol 9a and
3ˇ,17ˇ-di(tert-butyldimethylsilyloxy)-7˛-
benzyloxymethylandrost-5-en-7ˇ-ol 9b
Under similar conditions to those for the preparation of 7a
and 7b, 1 (100 mg, 0.19 mmol) was reacted with chloromethyl
benzyl ether (0.06 mL, 0.43 mmol) to afford a residue, which
was chromatographed on silica. Elution with petroleum
ether/ethyl acetate (25:1) gave 9a (16 mg, 13.0% yield): color-
less oil, [˛]D20 − 23.8 (c 2.20, n-C6H14). IR (KBr) ꢀmax (cm−1): 3471
(OH), 2955, 2856, 1664 (C C). 1H NMR (CDCl3) ı: 0.01 (d, 6H,
J = 3.6 Hz, (CH3)2Si), 0.06 (s, 6H, (CH3)2Si), 0.69 (s, 3H, 18-CH3),
0.87 (s, 9H, (CH3)3CSi), 0.89 (s, 9H, (CH3)3CSi), 0.94 (s, 3H, 19-
CH3), 3.20 (d, 1H, J = 9.2 Hz, 7-CH2OBn), 3.49 (d, 1H, J = 9.2 Hz,
7-CH2OBn), 3.49–3.57 (m, 2H, 3-H, 17-H), 4.53 (s, 2H, CH2Ph),